These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 29257114)
1. Amikacin: Uses, Resistance, and Prospects for Inhibition. Ramirez MS; Tolmasky ME Molecules; 2017 Dec; 22(12):. PubMed ID: 29257114 [TBL] [Abstract][Full Text] [Related]
2. Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc. Magallon J; Chiem K; Tran T; Ramirez MS; Jimenez V; Tolmasky ME PLoS One; 2019; 14(5):e0217602. PubMed ID: 31141575 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy. Saavedra S; Vera D; Ramírez-Ronda CH Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877 [TBL] [Abstract][Full Text] [Related]
4. Characterization of mutants of the 6'-N-acetyltransferase encoded by the multiresistance transposon Tn1331: effect of Phen171-to-Leu171 and Tyr80-to-Cys80 substitutions. Panaite DM; Tolmasky ME Plasmid; 1998; 39(2):123-33. PubMed ID: 9514709 [TBL] [Abstract][Full Text] [Related]
5. Dynamics and quantitative contribution of the aminoglycoside 6'- d'Udekem d'Acoz O; Hue F; Ye T; Wang L; Leroux M; Rajngewerc L; Tran T; Phan K; Ramirez MS; Reisner W; Tolmasky ME; Reyes-Lamothe R mSphere; 2024 Mar; 9(3):e0078923. PubMed ID: 38353533 [TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside resistance patterns in Turkey. Akalin HE; Torun M; Alacam R Scand J Infect Dis; 1988; 20(2):199-203. PubMed ID: 2840733 [TBL] [Abstract][Full Text] [Related]
7. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods]. Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314 [TBL] [Abstract][Full Text] [Related]
8. Enzymatic modification of aminoglycoside antibiotics in gentamicin-resistant gram-negative bacteria. Kettner M; Navarová J; Lebek G; Krcméry V Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):372-82. PubMed ID: 6091367 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by antisense oligodeoxynucleotides. Sarno R; Ha H; Weinsetel N; Tolmasky ME Antimicrob Agents Chemother; 2003 Oct; 47(10):3296-304. PubMed ID: 14506044 [TBL] [Abstract][Full Text] [Related]
14. Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications. Kondo S; Hotta K J Infect Chemother; 1999 Mar; 5(1):1-9. PubMed ID: 11810483 [TBL] [Abstract][Full Text] [Related]
15. Rise and dissemination of aminoglycoside resistance: the aac(6')-Ib paradigm. Ramirez MS; Nikolaidis N; Tolmasky ME Front Microbiol; 2013; 4():121. PubMed ID: 23730301 [TBL] [Abstract][Full Text] [Related]
16. The novel enzymatic 3''-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity. Hotta K; Sunada A; Ishikawa J; Mizuno S; Ikeda Y; Kondo S J Antibiot (Tokyo); 1998 Aug; 51(8):735-42. PubMed ID: 9766465 [TBL] [Abstract][Full Text] [Related]
17. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China. Xiao Y; Hu Y Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755 [TBL] [Abstract][Full Text] [Related]